The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer

BACKGROUND: There is limited evidence relating to the cost-effectiveness of treatments for localised prostate cancer. METHODS: The cost-effectiveness of active monitoring, surgery, and radiotherapy was evaluated within the Prostate Testing for Cancer and Treatment (ProtecT) randomised controlled tri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Br J Cancer
Hauptverfasser: Noble, Sian M., Garfield, Kirsty, Lane, J. Athene, Metcalfe, Chris, Davis, Michael, Walsh, Eleanor I., Martin, Richard M., Turner, Emma L., Peters, Tim J., Thorn, Joanna C., Mason, Malcolm, Bollina, Prasad, Catto, James W. F., Doherty, Alan, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Paez, Edgar, Rosario, Derek J., Rowe, Edward, Oxley, Jon, Staffurth, John, Neal, David E., Hamdy, Freddie C., Donovan, Jenny L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524753/
https://ncbi.nlm.nih.gov/pubmed/32669672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0978-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge